{"id":"W4391163000","doi":"10.1093/ecco-jcc/jjad212.0050","title":"DOP10 Risankizumab Versus Ustekinumab for the Achievement of Endoscopic Outcomes in Patients With Moderate-to-Severe Crohn’s Disease: Results From the Phase 3b SEQUENCE Trial","year":2024,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ustekinumab; Internal medicine; Clinical endpoint; Crohn's disease; Gastroenterology; Randomization; Randomized controlled trial; Intention-to-treat analysis; Abdominal pain; Surgery; Tumor necrosis factor alpha; Disease; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003187664,0.001151978,0.002369181,0.0002787346,0.0002757435,0.001161022,0.0006163841,0.001269916,0.004552216],"category_scores_gemma":[0.002244991,0.0003441615,0.002340935,0.0002978074,0.0008036562,0.0008500492,0.0004094896,0.002659162,0.0007914172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006025293,"about_ca_system_score_gemma":0.001012359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005905618,"about_ca_topic_score_gemma":0.00122415,"domain_scores_codex":[0.9987646,0.0008712471,0.00008326848,0.0001066471,0.0000745708,0.00009973281],"domain_scores_gemma":[0.9987651,0.0003834125,0.0003029067,0.00007638744,0.0001083236,0.0003639264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.982869,0.001742124,0.0005068449,0.0006190817,0.0008235571,0.00002098982,0.00002385956,0.0002518103,0.001234956,0.00006898765,0.0007298702,0.01110895],"study_design_scores_gemma":[0.9164519,0.07770719,0.002959552,0.0001028141,0.0009041772,0.00004510544,0.00002115935,0.0004578341,0.0003423696,0.0002207523,0.000771146,0.00001600813],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9746537,0.0154776,0.0005774912,0.001381897,0.0008135341,0.001971566,0.00153975,0.0001131843,0.003471203],"genre_scores_gemma":[0.9878584,0.004436652,0.000845034,0.001063763,0.0006466844,0.001616529,0.001569847,0.00002245957,0.001940748],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004552216,"threshold_uncertainty_score":0.01685822,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01748000887599214,"score_gpt":0.2859932374303216,"score_spread":0.2685132285543295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}